Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 1
1979 2
1980 1
1981 7
1983 3
1985 2
1986 3
1987 8
1988 4
1989 8
1990 6
1991 7
1992 11
1993 3
1994 13
1995 8
1996 4
1997 6
1998 9
1999 14
2000 25
2001 15
2002 17
2003 15
2004 16
2005 8
2006 10
2007 16
2008 11
2009 11
2010 14
2011 14
2012 9
2013 9
2014 9
2015 4
2016 4
2017 8
2018 8
2019 13
2020 11
2021 10
2022 10
2023 2

Text availability

Article attribute

Article type

Publication date

Search Results

363 results

Results by year

Filters applied: . Clear all
Page 1
Randomized Trial of Empagliflozin in Nondiabetic Patients With Heart Failure and Reduced Ejection Fraction.
Santos-Gallego CG, Vargas-Delgado AP, Requena-Ibanez JA, Garcia-Ropero A, Mancini D, Pinney S, Macaluso F, Sartori S, Roque M, Sabatel-Perez F, Rodriguez-Cordero A, Zafar MU, Fergus I, Atallah-Lajam F, Contreras JP, Varley C, Moreno PR, Abascal VM, Lala A, Tamler R, Sanz J, Fuster V, Badimon JJ; EMPA-TROPISM (ATRU-4) Investigators. Santos-Gallego CG, et al. Among authors: badimon jj. J Am Coll Cardiol. 2021 Jan 26;77(3):243-255. doi: 10.1016/j.jacc.2020.11.008. Epub 2020 Nov 13. J Am Coll Cardiol. 2021. PMID: 33197559 Free article. Clinical Trial.
SGLT2-Inhibitors on HFpEF Patients. Role of Ejection Fraction.
Requena-Ibanez JA, Santos-Gallego CG, Zafar MU, Badimon JJ. Requena-Ibanez JA, et al. Among authors: badimon jj. Cardiovasc Drugs Ther. 2022 Aug 3. doi: 10.1007/s10557-022-07371-7. Online ahead of print. Cardiovasc Drugs Ther. 2022. PMID: 35920946 Review.
Mechanistic Insights of Empagliflozin in Nondiabetic Patients With HFrEF: From the EMPA-TROPISM Study.
Requena-Ibáñez JA, Santos-Gallego CG, Rodriguez-Cordero A, Vargas-Delgado AP, Mancini D, Sartori S, Atallah-Lajam F, Giannarelli C, Macaluso F, Lala A, Sanz J, Fuster V, Badimon JJ. Requena-Ibáñez JA, et al. Among authors: badimon jj. JACC Heart Fail. 2021 Aug;9(8):578-589. doi: 10.1016/j.jchf.2021.04.014. JACC Heart Fail. 2021. PMID: 34325888 Free article. Clinical Trial.
Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics.
Santos-Gallego CG, Requena-Ibanez JA, San Antonio R, Ishikawa K, Watanabe S, Picatoste B, Flores E, Garcia-Ropero A, Sanz J, Hajjar RJ, Fuster V, Badimon JJ. Santos-Gallego CG, et al. Among authors: badimon jj. J Am Coll Cardiol. 2019 Apr 23;73(15):1931-1944. doi: 10.1016/j.jacc.2019.01.056. J Am Coll Cardiol. 2019. PMID: 30999996 Free article.
Empagliflozin Ameliorates Diastolic Dysfunction and Left Ventricular Fibrosis/Stiffness in Nondiabetic Heart Failure: A Multimodality Study.
Santos-Gallego CG, Requena-Ibanez JA, San Antonio R, Garcia-Ropero A, Ishikawa K, Watanabe S, Picatoste B, Vargas-Delgado AP, Flores-Umanzor EJ, Sanz J, Fuster V, Badimon JJ. Santos-Gallego CG, et al. Among authors: badimon jj. JACC Cardiovasc Imaging. 2021 Feb;14(2):393-407. doi: 10.1016/j.jcmg.2020.07.042. Epub 2020 Oct 29. JACC Cardiovasc Imaging. 2021. PMID: 33129742 Free article.
The anti-inflammatory effects of SGLT inhibitors.
García-Ropero Á, Santos-Gallego CG, Badimon JJ. García-Ropero Á, et al. Among authors: badimon jj. Aging (Albany NY). 2019 Aug 25;11(16):5866-5867. doi: 10.18632/aging.102175. Epub 2019 Aug 25. Aging (Albany NY). 2019. PMID: 31449492 Free PMC article. No abstract available.
From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I.
Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK, Koenig W, Lodder RA, March K, Demirovic J, Navab M, Priori SG, Rekhter MD, Bahr R, Grundy SM, Mehran R, Colombo A, Boerwinkle E, Ballantyne C, Insull W Jr, Schwartz RS, Vogel R, Serruys PW, Hansson GK, Faxon DP, Kaul S, Drexler H, Greenland P, Muller JE, Virmani R, Ridker PM, Zipes DP, Shah PK, Willerson JT. Naghavi M, et al. Among authors: badimon jj. Circulation. 2003 Oct 7;108(14):1664-72. doi: 10.1161/01.CIR.0000087480.94275.97. Circulation. 2003. PMID: 14530185 Review.
363 results